USDA Awards $600K Grant to Study How Hemp Genetics Affect Cannabinoid Production

9/28/2023

by

Virginia Tech’s College of Agriculture and Life Sciences was awarded a $600,000 U.S. Department of Agriculture grant to study the regulation of biosynthetic pathways for cannabinoid production. The research aims to better understand the pathway processes that could allow for better selection for, or modification of, plants with particular cannabinoid content, which could increase profit and reduce risk for growers as well as advance further use of cannabinoids in medical treatments. 

The researchers’ objectives are to study the gene regulatory networks that govern cannabinoid biosynthesis and to measure the effect of manipulation of the regulation on the metabolic profile of cannabis. This work could make possible a generation of new varieties, either through conventional or new plant breeding technologies, with enhanced, reduced, or abolished production of specific cannabinoid compounds, the college said in a press release. 

The project is led by Bastiaan Bargmann, assistant professor in the School of Plant and Environmental Sciences and affiliated faculty member with the Fralin Life Sciences Institute. It will be performed in collaboration with the Institute for Advanced Learning and Research in Danville, Virginia, and Canada’s York University. 

The U.S. legalized industrial hemp at the federal level in 2018 via the Farm Bill, a package of legislation that gets passed by Congress roughly every five years.

End

New York Attorney General’s Office Issues Stay in Leafly’s Challenge on Third-Party Marketing Ban

9/28/2023

by

The New York Attorney General’s Office last week agreed to a stay in cannabis technology company Leafly’s legal challenge to the state’s third-party marketing ban. The stay effectively blocks the state from enforcing the prohibition on Leafly, but not other third-party marketers.  

In a statement, Yoko Miyashita, CEO of Leafly, said that while the firm is “very pleased” with the decision, the company remains “concerned that the Office of Cannabis Management’s stance towards third-party platforms deprives consumers and licensed cannabis retailers with important tools that help them navigate legal cannabis.”  

“We’ll continue to work toward sensible regulations and are hopeful for a solution that empowers small businesses and supports consumer education and choice, while still protecting the public health, safety, and welfare of the people of New York.” — Miyashita in a press release 

The order does not end the lawsuit, which alleges that state regulators unfairly targeted third-party platforms in a misguided attempt to restrict the way retailers may market or promote their business and products and prevent price-shopping consumer behaviors. The lawsuit alleges, that the adoption of these regulations by the state is both arbitrary and capricious and a violation of the U.S. and New York constitutions. 

End

North Carolia House Passes Consumable Hemp and Kratom Regulation Bill

9/28/2023

by

House lawmakers in North Carolina last week unanimously passed a bill to regulate hemp-derived consumables and kratom. The measure would require businesses to get licenses to sell the products, includes testing provisions, and prohibits sales to anyone under 18 years old.

Eric Stahl, of The Burnt Pot Cannabis Café and Modern Apothecia, told WNCN that the law “is a perfect example” of the Legislature “trying to work on behalf of small business to create a platform” that allows current hemp industry operators to continue business. Stahl did, however, note that if the final version of the law caps THC levels at 3 milligrams it would likely remove “in the range of 95%” of products his business currently carries from store shelves.

“What we need to do is make sure that all the players are acting fairly, that these products are being tested correctly, and that we’re not allowing, most importantly, not allowing intoxicating products to wind up in the hands of children.” — Stahl to WNCN

The law does not include criminal penalties for product violations by retailers but would impose a $500 fine for first-time violations, a $750 fine for a second violation within three years, a fine of up to $1,000 and a 30-day license suspension for the third violation within three years of the first violation, and fines up to $2,000 and either a one-year license suspension or license revocation for four or more violations within three years of the first violation, according to a bill summary.

The measure would make it a misdemeanor to supply hemp products to anyone under the age of 18. The bill includes a fine structure for selling kratom to underage individuals but includes misdemeanor charges for youths who misrepresent their age to purchase the products.

The measure is currently in the Senate Committee on Rules and Operations.

End

SAFER Banking Act Passes Key Committee and Moves Next to Senate Floor

9/27/2023

by

The Secure and Fair Enforcement Regulation (SAFER) Banking Act has passed the Senate Committee on Banking, Housing and Urban Affairs and moves next to the Senate’s floor for consideration. The bipartisan effort is being led by Sens. Jeff Merkley (D-OR), Steve Daines (R-MO), Kyrsten Sinema (I-AZ), Cynthia Lummis (R-WY), and Senate Majority Leader Chuck Schumer (D-NY).

The proposal seeks to normalize banking access for cannabis companies operating in states with legal markets.

“This legislation will help make our communities and small businesses safer by giving legal cannabis businesses access to traditional financial institutions, including bank accounts and small business loans. It also prevents federal bank regulators from ordering a bank or credit union to close an account based on reputational risk.” — The co-sponsoring senators, in a statement

The proposal looks a lot like the bipartisan SAFE Banking Act, which has been introduced and passed seven times so far in the U.S. House, but which always failed to progress in the Senate — even when Democrats had full control of both Congressional chambers. The new bill aims for stricter regulations at the federal level, prohibiting banks from terminating cannabis-related accounts without “valid reason,” or for denying services based on “personal beliefs or political motivations,” the CNBC reported.

In a press release, National Cannabis Industry Association CEO Aaron Smith said:

“The committee’s approval of the SAFER Banking Act which gives hope to thousands of compliant, tax-paying businesses desperately trying to access the basic financial services other businesses take for granted. This uniquely bipartisan legislation has the potential to save lives and help small businesses; it’s time for Congress to get it to the president’s desk without further delay.”

So far, 39 U.S. states have passed legalization policies for adult use or medical purposes, and every single legal market has struggled with access to traditional banking services due to the plant’s ongoing federal prohibition.

End

Detroit Psychedelic Church Raided by Police

9/27/2023

by

Detroit Police last week raided the city’s first “psychedelic church,” operated by Soul Tribes, which offers psilocybin mushrooms as a holy sacrament, the Detroit Metro Times reports. The raid came days after the Metro Times published a cover story about the church. 

Owner Shaman Shu believes the raid violates Proposal E, which was approved by voters last year and decriminalized the possession of entheogenic plants and fungi, including psilocybin mushrooms, in the city. The church includes a “sacrament center” which sells dried psilocybin mushrooms, capsules, and gummies. 

According to a search warrant obtained by the Metro Times, the action included the seizure of all narcotics, including “psychedelic mushrooms” from the “illegal dispensary inside the purported church” along with “all books, records, receipts, notes, ledgers, and other papers relating to the procurement, distribution, storage, and transportation of controlled substances.” 

Shu told the Metro Times that officers seized more than $700,000 in psilocybin mushrooms intended for therapeutic use and ordered the church’s closure. Under Proposal E, therapeutic use of entheogenic plants and fungi was also decriminalized 

“They stole ancient sacrament. It was prayed over and meditated over. It’s a healing sacrament… They blocked my property down without due process. You can’t do that. … They think we’re not a church. But that’s why the federal government was created, to separate church and state so that cities do not opine on what churches are [and] what ministries are. We’re a ministry and a religious organization.” — Shu to the Metro Tims 

Detroit Police Department Sgt. for Media Relations Jordan Hall told the Metro Times that the raid “was due to a lack of licensing and the amount of substances that were distributed.” 

Mayor Mike Duggan’s office told the Metro Times that “It is the law department’s position that this local ordinance, despite its intent, does not override state law, which considers psilocybin to be a controlled substance” and that “the city ordinance itself does not allow for the sale or distribution of psilocybin.” 

End

MORE Act Reintroduced in Congress

9/27/2023

by

Congressional Democrats last week reintroduced the Marijuana Opportunity Reinvestment and Expungement (MORE) Act, which would decriminalize cannabis federally and implement criminal justice reforms. The measure would also impose a 5% federal cannabis tax on sales to fund three grant programs. 

The bill passed the House in 2020 and 2022 but was not taken up in the Senate. 

In a statement, Rep. Earl Blumenauer (D-OR), founder and co-chair of the Congressional Cannabis Caucus, described the measure as “the only comprehensive cannabis reform that has passed either chamber of Congress – twice.  

“It is the gold-standard, reflecting the concerns of businesses, researchers and impacted communities alike.” — Blumenauer in a press release 

Rep. Sheila Jackson Lee (D-TX), chair of the Subcommittee on Crime, Terrorism, and Homeland Security, added the bill would “take meaningful steps to address the harmful impacts of the federal prohibition, particularly on communities of color, and align federal law with that of many states.”  

The measure would also open up Small Business Administration funding for legitimate cannabis-related businesses and service providers, provide non-discrimination protections for cannabis use or possession, including, prohibiting the denial of any federal public benefit (including housing) based on the use or possession of cannabis, or prior cannabis-related conviction and provides that the use or possession of cannabis, or prior cannabis-related conviction, will have no adverse impact under the immigration laws. 

The measure is backed by the Leadership Conference on Civil and Human Rights, Drug Policy Alliance, NORML, Better Organizing to Win Legalization, and Minorities for Medical Marijuana, the Center for American Progress, and Students for Sensible Drug Policy. 

End

New York Lawmakers Urge Gov. to Sign Bill Allowing Cannabis Farmers to Sell to Tribes

9/27/2023

by

Nearly 70 New York lawmakers on Tuesday sent a letter to Gov. Kathy Hochul (D) urging her to sign the Cannabis Crop Rescue Act which would allow state-licensed cannabis farmers to sell their products to dispensaries located on Tribal lands in the state. The law passed the Legislature in June but Hochul has yet to sign it into law. 

New York’s adult-use rollout has been plagued by lawsuits, including one that has led to an injunction against any licensing under the current “conditional” rules that provided the first batch of retail licenses to social-equity applicants; however, in August, a judge found that the state broke its own rules by not including service-disabled military veterans in the Conditional Adult-Use Retail Dispensary program. Shortly after the decision, regulators announced they planned to open general licensing on October 4, which would likely end the legal challenge by veterans and related injunction.  

In the letter to Hochul, the lawmakers note that “there are over 200 cannabis farmers trying to sell their crops but only 23 dispensaries open statewide,” which “has resulted in more than 250,000 pounds of unsold cannabis.” 

During a Cannabis Control Board meeting earlier this month, regulators heard from farmers who complained about the slow rollout and the financial impact on their farms. 

“Farmers who took out loans and leveraged all their assets to cultivate these crops are demoralized and facing financial disaster unless we act quickly to provide them with an alternate market,” the lawmakers said in the letter. “Allowing these farmers to sell their cannabis to purchasing agents from New York’s Tribal Nations can be a short-term solution. These Tribal dispensaries would benefit from access to a source of local, safe, laboratory-tested products. Farmers would benefit from a new pathway to sell their products. Along with the Cannabis Grower’s Showcases, it could be the financial lifeline they need right now.” 

In a statement, Senate Agriculture Chair Michelle Hinchey (D) noted that “Many New York cannabis farmers are facing dire financial straits with unsold crops from last year, and time is running out to get products to market before they expire.” 

Assembly Agriculture Chair Donna Lupardo (D) added that the state owed a debt to the cannabis farmers who “took a risk” to grow the crop. 

“Many NY farmers are distressed for a number of reasons, but none more than this group,” she said in a statement. “Opening a one-time window for sales to Tribal Nations will provide some financial relief, while we are working on others means of recompense. There really is no time to waste, as this crop is degrading the longer it goes unsold.” 

Earlier this month, the Office of Cannabis Management said it would open 1,500 licenses when the window opens in October.  

End

House Committee Approves Bill to End Federal Ban on Cannabis Consumers Getting Security-Sensitive Jobs

9/26/2023

by

The House Committee on Oversight and Accountability last week voted 30-14 to advance a measure that would allow cannabis consumers to qualify for security clearances and become federal employees, GovExec reports. The bipartisan legislation, introduced by Reps. Jamie Raskin (D-Md) and Nancy Mace (R-SC), would end the practice of denying security clearances for federal employees who admit to past cannabis use. The proposal would also allow applicants who have been previously denied a federal job or security clearance in 2008 or later to seek reconsideration of that decision. 

Raskin indicated that he introduced the measure after a constituent said they were denied a job opportunity at the Centers for Medicare and Medicaid Services a week before their start date because they had admitted to using cannabis for medical purposes. 

“Despite the rapid expansion of all of these laws across the country, thousands of our constituents every year are being denied a federal security clearance or are losing the chance of obtaining federal employment solely because they admit honestly to having used marijuana in the past, even when it was completely lawful for them to do so.” — Raskin via GovExec 

When it was first introduced, the measure also barred the government from denying applicants for federal jobs or security clearances based on current cannabis use but the committee removed those provisions before approving it.  

Mace defended attacks from opponents of the bill who argue that cannabis is a dangerous drug, countering that if lawmakers are “concerned about dangerous substance use or abuse” they “ought to look first to alcohol, alcoholism and the addiction that runs there.” 

The measure moves next to the full House for consideration.  

End

Cannabis Legalization Bill Introduced in Wisconsin

9/26/2023

by

Two Wisconsin Democrats last week introduced bicameral legislation to legalize cannabis in the state. The measure was introduced in the Senate by Democrat Leader Melissa Agard, while the measure was introduced in the House by Rep. Darrin B. Madison. 

In a press release, Agard noted that “69% of Wisconsinites, including a majority of Republicans, support the full legalization of marijuana.”  

“I’ve said this time and time again – we know that the most dangerous thing about cannabis in Wisconsin is that it remains illegal. For the past decade, I have worked to undo Wisconsin’s antiquated and deeply-unjust marijuana policies and put our state on a prosperous path forward. This proposal will not only allow Wisconsin to right past wrongs, it will bring us in line with our neighbors and create countless opportunities to grow our economy and attract people to our state. Right now, we are seeing our hard earned money go across the border to Illinois, Michigan, and Minnesota to the tune of tens of millions of dollars each year. That is money we could be reinvesting to help support our friends and neighbors and make our state a place where people want to live, work, and play.” — Agard in a statement 

Madison added that cannabis legalization “is a matter of public safety and racial justice” in Wisconsin.   

“People in Wisconsin indulge in cannabis use, and deserve the ability to buy safe cannabis and use it responsibly without being criminalized. According to the ACLU, Black people were 4.24 times more likely to be arrested than white people in Wisconsin during 2018,” Madison said in a statement. “Similar disparities exist in convictions, leading to immeasurable harm to black communities in Wisconsin. The bill we’ve introduced today lays a solid foundation for those that have been harshly convicted for non-violent possession charges and the ramifications of those convictions.” 

End

Pennsylvania Senate Passes Bill to Allow More Licensed Cannabis Businesses to Sell Directly to Patients

9/26/2023

by

The Pennsylvania Senate last week passed a bill that would allow more licensed medical cannabis cultivators and processors in the state to sell directly to patients, PennLive reports. The measure passed 44-3 with bipartisan support. 

Under current state law, no more than five of the state’s 25 grower/processor license holders are allowed to act as dispensaries – all others must sell their products to a dispensary, which lawmakers say has created an imbalance in the system and created a near-monopoly.

State Sen. Chris Gebhard (R), the bill’s sponsor, suggested that the measure could be amended in the House to allow home cultivation by registered patients and perhaps full legalization provisions. However, state Sen. Dan Laughlin (R) told PennLive that if the bill “becomes a vehicle for adult use” he doesn’t believe it would pass the chamber.

“However, I think if they do add home-grown to this bill, it would strengthen the bill and I believe that we would be able to get it through this chamber as well.” — Laughlin to PennLive 

State Sen. Camera Bartolotta (R) told PennLive that she voted ‘no’ on the bill because it didn’t include home grow provisions.

“…I feel so strongly that we need to increase access to this medication for more Pennsylvanians by allowing them the option to grow a few plants at home,” she told PennLive.

State Sen. Sen. Sharif Street (D) added that he voted ‘yes’ to keep the measure alive but said “It is unconscionable that we continue to do this without addressing the issues that so many patients are having with cost, and the best way to do that is to allow home-grown in small amounts.”

The measure is currently in the House Health Committee.

End

NCAA Committee Recommends Removing Cannabis from Banned Substances List

9/25/2023

by

The NCAA Committee on Competitive Safeguards and Medical Aspects of Sports (CMAS) last week recommended removal of cannabis from its list of banned substances for all three divisions, calling instead for a “robust educational strategy.” The organization first announced in June they were considering the reforms. 

The committee concluded that removing cannabis from its testing protocols acknowledges the ineffectiveness of existing policy, which includes banning, testing, and penalizing; affirms the role of the NCAA drug-testing program to address only performance-enhancing substances; and emphasizes the importance of moving toward a harm-reduction strategy that prioritizes education and support at the school level over penalties. 

In a statement, James Houle, committee chair and lead sport psychologist at Ohio State, said that “When making a decision on an important topic like this, we agree that the membership should have an opportunity to vote on the final outcome.”  

“We are recommending a big shift in the paradigm when it comes to cannabinoids. We want to modernize the strategy with the most up-to-date research to give schools the best opportunity to support the health of student-athletes.” — Houle in a press release 

The NCAA said the recommendation “aims to recenter student-athlete health while recognizing membership opinions and the shifting cultural and legal landscapes surrounding cannabinoids” and that it is “based on extensive study informed by industry and subject matter experts” including doctors, substance misuse experts, and membership practitioners. 

In 2022, the CMAS raised its cannabinoid thresholds that lead to a failed test from 35 to 150 nanograms per milliliter of blood, aligning it with the policies of the World Anti-Doping Agency.   

End

Minnesota’s Newly Appointed Top Cannabis Regulator Steps Down After One Day

9/25/2023

by

Minnesota’s head of the Office of Cannabis Management (OCM) stepped down on Friday – one day after she was appointed – following a report that her hemp business sold products that exceeded allowable THC levels, owned money to former associates, and had tens of thousands of dollars in tax liens, according to MPR News.

Erin DuPree, founder, vice president of sales and operations, and head of research and development of Loonacy Cannabis Co. was appointed by Gov. Tim Walz (D) on Thursday, but a subsequent investigation by MPR News-APM Reports uncovered that Loonacy had advertised products with THC content higher than what was legally allowed starting in July 2022 and had advertised vape products containing THC, which, at the time, were prohibited under the law.

In a statement announcing her resignation, DuPree pushed back on those claims, saying her company has “never knowingly sold any noncompliant product,” and that when she “became aware of them” she “removed the products from inventory.”

“Conducting lawful business has been an objective of my business career. However, it has become clear that I have become a distraction that would stand in the way of the important work that needs to be done.” — DuPree, in a statement, via MPR

In an interview with MinnPost following DuPree’s resignation, Walz admitted officials “got this wrong.”

“Not the finest hour,” Walz told MinnPost. “In this case, the process did not work.”

Walz added that DuPree was chosen because he wanted someone who understood Minnesota’s cannabis industry but that citizens expect regulators will “follow the rules.”

“I own this one,” Walz said, “we’ll get the right person in there.”

Charlene Briner, a senior Department of Agriculture official who has been serving as the interim OCM director, will continue to lead the agency in the absence of a full-time department chief.

End

Illinois County Requiring Dispensaries to Warn That ‘Cannabis Use May Contribute to Mental Health Problems’

9/25/2023

by

Cannabis dispensaries in McHenry County, Illinois are now required to display signs with a warning that “cannabis use may contribute to mental health problems” under “first-in-the-country” rules imposed by McHenry County State Attorney Patrick Kenneally, Axios reports. Businesses that don’t comply could face consumer fraud lawsuits from Kenneally.  

Kenneally defended the new order in a Chicago Tribune op-ed in which he suggests a “growing body of research” that “cannabis can … initiate and worsen depression, bipolar disorder, anxiety and suicidal ideation, especially in young people.” He further claims that “about half” of the county’s recent homicides “involve cannabis or cannabis-induced psychosis” and that “cases of driving while under the influence of cannabis have doubled.” 

In a statement to Axios, the Illinois Cannabis Regulation Oversight Office said Gov. J.B. Pritzker (D) was “disappointed to learn that the McHenry County state’s attorney prefers focusing on spreading disinformation instead of tackling the issues that actually keep residents safe.” 

“Legalizing adult-use cannabis has always been about justice, safety, and equity in Illinois,” the agency said in the statement. 

A group of Democratic state lawmakers, issued their own statement pushing back on Kenneally’s op-ed, saying he “carelessly conflates cannabis use with the most complex societal issues that our own Illinois researchers, institutions, and community leaders work collectively every day to further understand and improve upon.”  

“At best, Kenneally misleads weekend editorial readers,” the statement reads. “At worst, he continues an unfortunate tradition in American history of using hyperbole to vilify cannabis use and possession, including for medical purposes.” 

End

Square Partners With Jane Technologies to Service Canadian Cannabis Industry

9/22/2023

by

Payments processing firm Square announced this week that it was partnering with cannabis e-commerce company Jane Technologies to enter the Canadian cannabis market. Square — which is a subsidiary of Block Inc., and which was founded by Twitter co-founder Jack Dorsey — plans to launch its retail point-of-sale services for licensed dispensaries in Ontario first, according to a press release, with plans to expand to other provinces after having taken time to “get it right.”

Additionally, through its partnership with Jane Technologies, companies who sign up for Square’s retail payments system will also be able to utilize the former’s e-commerce platform for online sales.

Jane CEO Socrates Rosenfeld said that Square’s reputation as a global commerce platform “speaks for itself,” and the company is “thrilled to integrate the robust infrastructure of Square’s point-of-sale and APIs with the powerful Jane e-commerce platform to unlock a best-in-class omnichannel experience for Canadian cannabis retailers.”

Roshan Jhunja, Head of Retail at Square, said the company recognized the unique limitations facing cannabis retailers “when it comes to reliable and integrated commerce tools.”

“Sellers are looking for an easy-to-use, fully integrated omnichannel solution to help them run their businesses in person and online. We’ve been fortunate to partner with Jane to develop a robust online offering and encourage cannabis dispensaries to test our software, hardware and payment solution in person through our Early Access Program.” — Jhunja, in a press release

Canada became the first North American country to legalize adult-use cannabis in 2018.

End

Republican Lawmakers Urge DEA to Reject Cannabis Reclassification

9/22/2023

by

In a letter to Drug Enforcement Administration (DEA) Administrator Anne Milgram, 14 Republican lawmakers urged the agency to reject the Department of Health and Human Services (HHS) recommendation to reclassify cannabis from Schedule I under the Controlled Substances Act to Schedule III. 

“It is irresponsible for HHS to recommend that marijuana be removed from Schedule I. It would also be irresponsible for DEA to act on this recommendation,” the letter states. “Our country relies on DEA to enforce our nation’s drug laws. We ask you to uphold your mission by rejecting any effort to remove marijuana from Schedule I.”

The letter cites National Institute on Drug Abuse (NIDA) research that suggests that 30% of cannabis consumers have marijuana use disorder, claims that cannabis has higher THC content than 25 years ago, an American Academy of Pediatrics study that suggests a 1,375% increase in accidental cannabis edible ingestion by children under 6 between 2017 and 2021, and previous DEA denials of petitions to reclassify cannabis.

The letter contends that cannabis “does not have a currently accepted medical use,” and notes that the Food and Drug Administration (FDA) approved drugs that contain either natural or synthetic cannabis are non-intoxicating.

“The FDA has never approved marijuana as a treatment for any disease or condition,” the letter states.

The letter is signed by Senators James Lankford and Markwayne Mullin (OK), Michael Rounds (SD), Mike Crapo and James Risch (ID), Marsha Blackburn (TN), Ted Budd (NC), and Tom Cotton (AR), along with Representatives Pete Sessions (TX), Chuck Edwards (NC), Robert Aderholt (AL), Hal Rogers (KY), Earl “Buddy” Carter (GA), and Andy Biggs (AZ).

End

Studies Find Many Maine Medical Cannabis Products Fail Adult-Use Testing Protocols

9/22/2023

by

A study conducted by Maine’s Office of Cannabis Policy (OCP) found 45% of medical cannabis samples subject to the same testing as adult-use products would have failed the protocols for containing either pesticides, yeast and mold, or harmful microbes, the Portland Press Herald reports. A separate study by Nova Analytic Labs, one of the state’s four licensed cannabis testing labs, found that about 21% of medical cannabis samples would have failed the state’s adult-use testing panel.

The OCP study included 127 samples from the medical cannabis market and, of those, 57 would have failed under the adult-use testing regime, the report says. The Nova study included about 1,400 samples of medical cannabis which had a much higher failure rate than the samples collected from the adult-use market, which was 4% of 3,200 samples.

In Maine, medical cannabis is not required to be tested, while products from the adult-use market are.

Christopher Altomare, CEO of Nova, told the Press Herald that the medical cannabis samples were provided voluntarily by caregivers who were already choosing to test their products, rather than a randomized selection, so it’s likely the real percentage is much higher. He noted that 10% to 20% of Nova’s business comes from the medical market but they are testing for potency, not pesticides.

“We need thoughtful testing regulations in the medical market. At the end of the day, what we do is public and patient safety and I don’t feel that Maine patients are being adequately protected.” — Altomare to the Press Herald 

Medical cannabis sales in Maine topped $305 million in 2022. In August there were about 1,900 medical cannabis caregivers registered with the state. A report in April from OCP found that from the end of 2021 to the end of January 2023 more than 1,350 medical cannabis caregivers left the program.  

OCP is seeking to institute testing requirements for medical cannabis sold in the state but have faced pushback from caregivers who say the protocols would be costly. During a webinar on Tuesday, OCP Director John Hudak suggested the agency might begin requiring the testing of medical products. 

“If a business model is one in which producing clean cannabis is too costly, there’s something wrong with the business model,” he said. “We’re not going to focus on profits at the expense of patients’ health.” 

Hudak noted that despite being a registered medical cannabis patient, he doesn’t use medical cannabis in Maine because of the lack of testing. 

End

Minnesota Appoints Head of Office of Cannabis Management

9/22/2023

by

Minnesota’s newly appointed head of its Office of Cannabis Management (OCM), Erin DuPree, estimates that it will take about two or three years before the state launches adult-use sales, FOX 9 reports. DuPree was named to the post on Thursday but will officially begin her duties on October 2.  

“We don’t have to reinvent the wheel here. We’re lucky as the 23rd state to legalize, we can look back on the other 22 states and see what’s been good and what’s not been good and use that to help make policy here.” — DuPree via FOX 9 

DuPree is the founder, vice president of sales and operations, and head of research and development at Loonacy Cannabis Co. but indicated that she plans to divest herself from the business prior to her October start date at OCM.

In a press release announcing DuPree’s appointment, Gov. Tim Walz (D) noted DuPree has “direct experience in Minnesota’s hemp and cannabis industry and over 20 years of success in launching, managing, and growing businesses and organizations.”

“DuPree is a proven and effective leader,” Walz said in the statement, “who will be successful in standing up Minnesota’s new adult-use cannabis market and helping Minnesotans succeed in the industry.”

The agency last week posted nine new positions and will need about 150 employees total.

“It is an honor to join the Walz-Flanagan administration as the first director of the new Office of Cannabis Management,” DuPree said in a statement. “I look forward to working closely with all of the legislators, stakeholders, and advocates who worked so hard to pass this new law and am committed to the work of ensuring Minnesota’s new adult-use cannabis industry will grow and thrive for years to come.”

End

Leafly Sues New York Cannabis Regulators Over Third-Party Marketing Ban

9/21/2023

by

Cannabis technology firm Leafly is suing cannabis regulators in New York over the state’s third-party marketing ban included in its recent regulations package, Spectrum News reports. Ryan McCall, deputy cannabis practice chair at Tully Rinckey said that while the third-party marketing ban has been in place under New York’s rules, which he described as a pilot program, Leafly’s lawsuit challenges the prohibition included in the state’s final regulations, which were unveiled last week.

“Now what we’re seeing with finalization, what is going to be the roadmap for New York state cannabis moving forward, you’re now having issues where, hey we can’t go to third party marketing firms, we can’t go to any type of third party advertising, third party distributing. It somewhat pigeonholes a lot of businesses that could be involved within New York State commerce to market it and grow cannabis.” — McCall to Spectrum News

Leafly, McCall explained, “is a platformer that effectively allows anybody who’s interested with cannabis, not just in New York state but throughout the country to be able to look at reviews, sometimes be directed to place orders, you’re able to purchase advertising from the individual dispensary, distributor, etc.”

New York’s rules, which were promulgated amid another lawsuit that has halted licensing in the state, are set to take effect October 4 and would open licensing for the general public – up until now, licensing has only been available to social-equity applicants affected by the enforcement of cannabis prohibition.

McCall said the lawsuit by Leafly “could put another roadblock yet again” but that it’s likely it could be settled “relatively quickly.”

End

Oklahoma Crackdown Shuts Down Five Medical Cannabis Businesses for Alleged Diversion

9/21/2023

by

A crackdown by authorities in Kay County, Oklahoma led to the confiscation of 4,800 pounds of cannabis and five businesses shut down, KOCO reports. The operation was led by the Oklahoma Medical Marijuana Authority (OMMA) and was prompted by both routine inspections of licensed medical cannabis businesses and civilian complaints.  

 Mel Woodrow, chief of enforcement and compliance at OMMA, told KOCO that the action was the first time the agency had conducted such an operation.  

“Large quantities that are not in the seed-to-sale tracking system, the METRC system. It’s not tagged. In no way could they account for where that marijuana should be going, or where it came from. Large amounts of marijuana were being diverted, it was pretty common knowledge.” — Woodrow to KOCO 

The crackdown comes as Oklahoma officials try to reign in the state’s medical cannabis program. A study by Cannabis Public Policy Consulting commissioned by OMMA found that growers in the state were producing 64 times more cannabis than needed for the state’s patient population while data from Oklahoma’s Bureau of Narcotics and Dangerous Drugs estimates that about 2,000 medical cannabis licensees in the state are obtained fraudulently or are masking illicit sales. Last month, the Oklahoma Bureau of Narcotics (OBN) said that over the last two years, it has shut down more than 800 unlawful cannabis farms operating under the guise of the state’s medical cannabis law, leading to the confiscation of nearly 7,000 pounds of cannabis and more than 200 arrests.  

Officials said the action in Kay County would serve as a blueprint to uncover illegal operators throughout the state.  

End

Kentucky Commission Considering Psychedelic Ibogaine as Treatment for Opioid Addiction

9/21/2023

by

The Kentucky Opioid Abatement Advisory Commission is considering the psychedelic ibogaine as a treatment for opioid addiction, National Public Radio affiliate WKU reports. The commission heard from more than a dozen people about their personal and professional experiences with the substance and its role in treating opioid addiction during its recent meeting. 

Ibogaine has gained recognition recently for its potential to treat severe PTSD and opioid addiction while minimizing withdrawal symptoms. But it is still classified as a Schedule I substance under federal law and is not approved for distribution by the Food and Drug Administration (FDA).   

Joseph Peter Barsublia, a psychologist who runs a psychedelic treatment center in Mexico, told the panel that from what he has “repeatedly witnessed firsthand” the psychedelic “is a revolutionary and paradigm-changing treatment” but he warned that “it is by no means a cure-all or a panacea.”  

In 2022, 2,135 people died from drug overdoses in Kentucky and while the state saw a decrease of about 5% in overdose deaths compared to 2021, the deaths remained higher than they were before the COVID-19 pandemic began. Since 2018, nearly 9,000 people have died from overdoses, according to state data. 

The commission will decide in the next few months where to invest $42 million of Kentucky’s nearly $900 million in opioid lawsuit settlement funds. If the commission votes to allocate the money, Kentucky would become the first state to research ibogaine for its potential uses in opioid addiction recovery. 

End

The Craft Cannabis Industry: Following in the Footsteps of Craft Beer

9/21/2023

by

In recent years, the cannabis industry has undergone a transformation, evolving from an underground, unregulated market to a legal and burgeoning sector. Within this transformation, a trend has emerged that seems to parallel the growth of another well-established industry: craft beer. Just as craft beer disrupted the traditional beer market and captivated consumers with unique “niche” offerings, the craft cannabis market is set to mirror this trajectory, offering high-quality products and a very personalized experience.

Roots of the Craft Movement

To understand the parallels between craft cannabis and craft beer, we must first delve into the origins of the craft movement itself. Craft beer emerged as a reaction against mass-produced, flavorless beers that dominated the market. Similarly, the craft cannabis movement is a popular counterpart to the standardized, mass-produced cannabis products that became prevalent following its legalization in various regions. Just as craft beer enthusiasts sought complexity, distinct flavors, and local character in their beverages, consumers in the cannabis space are now seeking unique strains, nuanced aromas, differentiated form factors, and specialized effects.

Quality Over Quantity

One of the central tenets of both the craft beer and craft cannabis movements is the emphasis on quality over quantity. Craft beer producers prioritize ingredients, brewing techniques, and innovative flavors, which has led to a renaissance of beer varieties. Likewise, craft cannabis cultivators focus on cultivation methods, genetic diversity, and unique manufacturing technologies to produce products with diverse cannabinoid and terpene profiles. This emphasis on quality has given rise to a diverse array of cannabis products, each catering to different preferences and needs.

Local and Artisanal Appeal

Craft beer’s appeal often lies in its local and artisanal nature. Breweries, often small and independently owned, become pillars of their communities, creating a sense of connection and loyalty among consumers. Similarly, craft cannabis cultivators are fostering a local and artisanal ethos. Small-scale cannabis farms are popping up, cultivating strains unique to their region and reflecting the local climate, soil, and culture. This localization creates a bond between consumers and producers, mirroring the connection fostered between craft beer enthusiasts and their local breweries.

Education and Appreciation

Both industries share a common goal: educating consumers about the intricate processes involved in crafting their products. Craft beer aficionados have embraced the art of brewing, learning about malts, hops, yeast strains, and brewing methods. Similarly, the craft cannabis movement encourages consumers to appreciate the complexities of different strains, understand the significance of cannabinoids and terpenes, and explore various consumption methods. This educational aspect not only elevates the consumer experience but also creates a culture of informed enthusiasts.

Diverse Consumption Experiences

The craft beer industry is known for its diverse range of styles, catering to a broad spectrum of preferences, from hoppy IPAs to rich stouts. Likewise, the craft cannabis industry offers an array of consumption methods, from traditional smoking to vaporizing, edibles, beverages, tinctures, and topicals, amongst others. This variety allows consumers to choose the method that best suits their preferences and lifestyles, contributing to the personalization and customization that defines the craft movement.

Regulations and Challenges

However, both industries also face common challenges, particularly in terms of regulations. Craft beer producers often struggle with regulations that favor larger beer corporations, making it difficult for small breweries to compete on an equal footing. Similarly, the craft cannabis industry faces regulatory hurdles that can hinder small-scale cultivators. Striking a balance between ensuring product safety and allowing smaller players to thrive is a challenge that both industries must navigate.

The Future of Craft Cannabis

As the craft cannabis industry continues to develop, it is positioned to follow the trajectory of craft beer, albeit with its unique challenges and opportunities. While there will be obstacles to overcome, the demand for high-quality, locally sourced, and artisanal cannabis products is expected to grow. Just as craft beer transformed the beer landscape, the craft cannabis movement is reshaping the cannabis experience, appealing to consumers’ desire for quality, diversity, education, and community.

In conclusion, the parallels between the craft cannabis and craft beer industries are undeniable. Both movements have emerged as responses to mass production, offering quality, diversity, education, and a sense of community. As the craft cannabis industry gains momentum, it is poised to mirror the success and impact of craft beer, providing consumers with an elevated and personalized experience that reflects the values of the modern era.

End

CannaCon Detroit 2023: Where The Cannabis Industry Does Business

9/20/2023

by

Detroit, MI — CannaCon Detroit, the premier event for the cannabis industry, is back and better than ever for its 2023 edition. This year’s event promises to bring together professionals, experts, and enthusiasts from all corners of the cannabis world, providing a platform for networking, learning, and exploring the latest innovations in the rapidly evolving industry. The event is scheduled to take place October 6th and 7th at Huntington Place.

Seminar Highlight: Calvin Johnson Jr. and Rob Sims share insights on growing your brand through innovation and education.

One of the highly anticipated seminars at CannaCon Detroit 2023 features two esteemed speakers: Calvin Johnson Jr. and Rob Sims. Both distinguished former NFL players, Johnson and Sims have transitioned their careers from the football field to the cannabis industry, leveraging their experiences and expertise to drive positive change.

CannaCon Detroit 2023: Beyond the Seminars

CannaCon Detroit 2023 offers attendees a multifaceted experience. The event will feature an expansive expo hall showcasing the latest products, technologies, and services within the cannabis sector. From cultivation and extraction to marketing and distribution, the expo will cater to every aspect of the industry.

Moreover, the event’s agenda includes a diverse range of seminars, led by industry thought leaders. Topics will span legal and regulatory updates, market trends, sustainability practices, and advancements in cannabis research. Including a special presentation on grow tips and tricks from Mike the founder of Exotic genetics.

Networking opportunities abound, allowing attendees to connect with professionals, entrepreneurs, investors, and advocates who share a passion for the cannabis industry’s growth and potential.

Registration for CannaCon Detroit 2023 is now open, For more information about the event, including registration details, the full seminar schedule, and exhibitor information, please visit cannacon.org

Join us at CannaCon Detroit 2023 and be a part of the conversation driving innovation, education, and progress within the dynamic cannabis industry.

Media Contact:
Angela Grelle: Director of Marketing and PR
CannaCon Email: angela@cannacon.org

End

CBD news and information

CBD Industry Group Submits Study on CBD Intake Limits to Congress, FDA

9/20/2023

by

A coalition of CBD companies known as ONE HEMP, which aims to engage Congress and the Food and Drug Administration (FDA), have submitted a study to U.S. officials that shows upper intake limits of 70 milligrams of CBD per day is safe for healthy adults. The study also found upper intake limits of 160 milligrams per day are safe for healthy adults who are not trying to conceive, are pregnant, or lactating.  

The study was submitted following a Request for Information from House and Senate committees and was specifically designed to address concerns previously raised by the FDA that CBD is potentially harmful to liver and reproductive health.  

In a statement, Dr. Rayetta G. Henderson Ph.D., senior managing scientist at ToxStrategies LLC, which conducted the study, said the research found the suggested upper intake limits for CBD for healthy adults “closely correspond with the recommendations put forth by leading regulatory bodies,” including Health Canada, Australia’s Therapeutic Goods Administration, and the U.K.’s Food Standards Agency.  

Dr. Marcel Bonn-Miller Ph.D., chief scientific officer at Charlotte’s Web and part of the research team, said the study “will help to inform legislators and regulators as they determine manufacturing and labeling requirements for supplement products containing CBD.” 

“Implementing scientifically based safety limits is crucial to protecting consumers. This research is also aligned with ONE HEMP’s recommendations for accurate product labeling and, ultimately, holding CBD companies accountable for manufacturing and selling quality and safe products.” — Bonn-Miller in a press release 

Charlotte’s Web is a founding member of ONE HEMP, whose goal is to work toward more stringent regulatory standards, including independent third-party testing and accurate labeling, the company said in a press release. 

Jared Stanley, co-founder and COO of Charlotte’s Web, said the CBD market needs “clarity and stability” and that “it is time for Congress to clarify the FDA’s mandate and definitively regulate CBD products as dietary supplements once and for all.” 

The peer-reviewed study submitted by ONE HEMP was published online August 25 in the Regulatory Toxicology and Pharmacology.

End

New York Regulators Remove Video of Meeting Where Community is Critical of Adult-Use Rollout

9/20/2023

by

In a video previously posted online of its September 12 meeting, New York’s Office of Cannabis Management scrubbed the public comment period, which included complaints about the rollout of the adult-use cannabis program by growers, retailers, and licensees, according to report by The City. As of Wednesday morning, the video was no longer available on YouTube, with an error message saying it had been “removed by the uploader.” 

Comments removed from the video, prior to it being taken offline, included those by Tess Interlicchia, a cannabis farmer, who told the Cannabis Control Board that her business has “lost millions of dollars.”   

“We’ve done everything right and I can’t feed my children. I sold my tractors to the farm in January. It’s now September. I have nothing left to sell.” — Interlicchia via The City 

In a response to Jeff Jones, a licensed cultivator in the state, about why the public comments were removed, Aaron Ghitelman, the spokesperson for the Office of Cannabis Management, said the comment period was removed because officials were “Trying not to amplify the threats of self-harm/ violence that occurred during the meeting,” the report says.  

According to The City report, during the public comment period, one farmer said she “wore a noose around her neck” the day of the meeting because she felt like she was “gonna hang” herself. 

In a statement to The City, Ghitelman said “The Office of Cannabis Management is in the process of editing the video of the recent Cannabis Control Board meeting to remove a short section during which an individual made a threat of self-harm and violence” and that “the full video, absent these comments, will be posted once the editing process is complete.” 

End